Merrimack Pharmaceuticals
MACK
#8395
Rank
โ‚น20.50 B
Marketcap
โ‚น1,387
Share price
0.00%
Change (1 day)
8.75%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): โ‚น1,156

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,270. In 2016 the company made an earnings per share (EPS) of -โ‚น1,121 an increase over its 2015 EPS that were of -โ‚น1,210.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)โ‚น1,156
2016-โ‚น1,121-7.35%
2015-โ‚น1,21065%
2014-โ‚น733.13-39.39%
2013-โ‚น1,210-54.01%
2012-โ‚น2,630

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น339.59-73.26%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-โ‚น11.00-100.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น173.20-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น76.98-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,030-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA